Vitexicarpin acts as a novel angiogenesis inhibitor and its target network

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zhang, Bo ^a,b   Liu, Lu ^a   Zhao, Shiwen ^a   Wang, Xu ^a   Liu, Liyang ^a   Li, Shao ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Tianjin International Joint Academy of Biotechnology and Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CASTICIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHORIOALLANTOIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SARCOMA; STRUCTURE ACTIVITY RELATION; UMBILICAL VEIN ENDOTHELIAL CELL; VITEX ROTUNDIFOLIA; WOUND HEALING;

EID: 84874827334     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/278405     Document Type: Article

References (53)

1. Jain R. K., Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Medicine 2001 7 9 987 989 2-s2.0-0034796595 10.1038/nm0901-987 (Pubitemid 32937367)
2. Carmeliet P., Angiogenesis in life, disease and medicine. Nature 2005 438 7070 932 936 2-s2.0-30744479430 10.1038/nature04478 (Pubitemid 43093958)
3. Wang S., Zheng Z., Weng Y., Yu Y., Zhang D., Fan W., Dai R., Hu Z., Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sciences 2004 74 20 2467 2478 2-s2.0-1542376217 10.1016/j.lfs.2003.03.005 (Pubitemid 38324603)
4. Fan T. P., Yeh J. C., Leung K. W., Yue P. Y. K., Wong R. N. S., Angiogenesis: from plants to blood vessels. Trends in Pharmacological Sciences 2006 27 6 297 309 2-s2.0-33744902836 10.1016/j.tips.2006.04.006 (Pubitemid 43850005)
5. Mochizuki M., Yung Choon Yoo, Matsuzawa K., Sato K., Saiki I., Tono-Oka S., Samukawa K. I., Azuma I., Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside- Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of Red ginseng. Biological and Pharmaceutical Bulletin 1995 18 9 1197 1202 2-s2.0-0029098678
6. Chen M. W., Yang L., Ni L., Huang C., The effects of 20(R)-Rg3 on lung carcinoma A549 cell line and endogenous VEGF secreted by tumor cells. Journal of Sichuan University 2006 37 1 60 62 2-s2.0-31544434537 (Pubitemid 43155941)
7. Hu K. B., Liu Z. H., Liu D., Li L. S., Inhibition of vascular endothelial growth factor expression and production by triptolide. Planta Medica 2002 68 4 368 369 2-s2.0-0036247518 10.1055/s-2002-26737 (Pubitemid 34494054)
8. Wang B., Ma L., Tao X., Lipsky P. E., Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis and Rheumatism 2004 50 9 2995 3003 2-s2.0-4444370034 10.1002/art.20459 (Pubitemid 39209539)
9. Li S., Lu A. P., Wang Y. Y., Li Y. D., Suppressive effects of a Chinese herbal medicine Qing-Luo-Yin extract on the angiogenesis of collagen-induced arthritis in rats. American Journal of Chinese Medicine 2003 31 5 713 720 2-s2.0-2142651613 10.1142/S0192415X03001430 (Pubitemid 41758795)
10. Kok T. W., Yue P. Y. K., Mak N. K., Fan T. P. D., Liu L., Wong R. N. S., The anti-angiogenic effect of sinomenine. Angiogenesis 2005 8 1 3 12 2-s2.0-24044455371 10.1007/s10456-005-2892-z (Pubitemid 41223834)
11. Li S., Zhang B., Zhang N., Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Systems Biology 2011 5 supplement 1, article S10 2-s2.0-79959199033 10.1186/1752-0509-5- S1-S10
12. Hou D. X., Kumamoto T., Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxidants and Redox Signaling 2010 13 5 691 719 2-s2.0-77954624176 10.1089/ars.2009.2816
13. Díaz F., Chávez D., Lee D., Mi Q., Chai H. B., Tan G. T., Kardono L. B. S., Riswan S., Fairchild C. R., Wild R., Farnsworth N. R., Cordell G. A., Pezzuto J. M., Kinghorn A. D., Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo. Journal of Natural Products 2003 66 6 865 867 2-s2.0-0038203580 (Pubitemid 36782101)
14. Kobayakawa J., Sato-Nishimori F., Moriyasu M., Matsukawa Y., G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.). Cancer Letters 2004 208 1 59 64 2-s2.0-13244249141 10.1016/j.canlet.2004.01.012 (Pubitemid 38501784)
15. You K. M., Son K. H., Chang H. W., Kang S. S., Kim H. P., Vitexicarpin, a flavonoid from the fruits of Vitex rotundifolia, inhibits mouse lymphocyte proliferation and growth of cell lines in vitro. Planta Medica 1998 64 6 546 550 2-s2.0-0031856869 (Pubitemid 28383889)
16. Lee S. M., Lee Y. J., Kim Y. C., Kim J. S., Kang D. G., Lee H. S., Vascular Protective Role of Vitexicarpin Isolated from Vitex rotundifolia in Human Umbilical Vein Endothelial Cells. Inflammation 2011 35 584 593 2-s2.0-79956272412 10.1007/s10753-011-9349-x
17. Li S., Zhang B., Jiang D., Wei Y., Zhang N., Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010 11 supplement 11, article S6 2-s2.0-78650832745 10.1186/1471-2105-11-S11-S6
18. Paterson I., Anderson E. A., The renaissance of natural products as drug candidates. Science 2005 310 5747 451 453 2-s2.0-27144547510 10.1126/science.1116364 (Pubitemid 41507948)
19. Hopkins A. L., Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 2008 4 11 682 690 2-s2.0-54249155522 10.1038/nchembio.118
20. van der Greef J., McBurney R. N., Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nature Reviews Drug Discovery 2005 4 12 961 967 2-s2.0-31144438390 10.1038/nrd1904
21. Berger S. I., Ma'ayan A., Iyengar R., Systems pharmacology of arrhythmias. Science Signaling 2010 3 118 ra30 2-s2.0-77953720204 10.1126/scisignal.2000723
22. Burkard T. R., Rix U., Breitwieser F. P., Superti-Furga G., Colinge J., A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib. PLoS Computational Biology 2010 6 11 2-s2.0-78649683041 10.1371/journal.pcbi.1001001 e1001001
23. Wu X., Jiang R., Zhang M. Q., Li S., Network-based global inference of human disease genes. Molecular Systems Biology 2008 4 189 199
24. Barabási A. L., Gulbahce N., Loscalzo J., Network medicine: a network-based approach to human disease. Nature Reviews Genetics 2011 12 1 56 68 2-s2.0-78650373804 10.1038/nrg2918
25. Li S., Framework and practice of network-based studies for Chinese herbal formula. Journal of Chinese Integrative Medicine 2007 5 5 489 493 2-s2.0-34648827366 10.3736/jcim20070501 (Pubitemid 47455595)
26. Li S., Network systems underlying traditional Chinese medicine syndrome and herb formula. Current Bioinformatics 2009 4 3 188 196 2-s2.0-70549112019 10.2174/157489309789071129
27. Zhao J., Jiang P., Zhang W., Molecular networks for the study of TCM pharmacology. Briefings in Bioinformatics 2009 11 4 417 430 2-s2.0-77955039434 10.1093/bib/bbp063 bbp063
28. Li S., Network target: a starting point for traditional Chinese medicine network pharmacology. Zhongguo Zhong Yao Za Zhi 2011 36 2017 2020
29. Zhao S., Li S., Network-based relating pharmacological and genomic spaces for drug target identification. PLoS ONE 2010 5 7 2-s2.0-77955628292 10.1371/journal.pone.0011764 e11764
30. Fierro F. A., Kalomoiris S., Sondergaard C. S., Nolta J. A., Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 2011 29 11 1727 1737 10.1002/stem.720
31. Richardson M., Singh G., Observations on the use of the avian choriallantoic membrane (CAM) model in investigations into angiogenesis. Current Drug Targets-Cardiovascular and Haematological Disorders 2003 3 2 155 185 2-s2.0-0038103790 10.2174/1568006033481492 (Pubitemid 36621799)
32. Wishart D. S., Knox C., Guo A. C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M., DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research 2008 36 1 D901 D906 2-s2.0-38549151817 10.1093/nar/gkm958 (Pubitemid 351149842)
33. Xie X. Q., Chen J. Z., Data mining a small molecule drug screening representative subset from NIH PubChem. Journal of Chemical Information and Modeling 2008 48 3 465 475 2-s2.0-42149150001 10.1021/ci700193u (Pubitemid 351535416)
34. Keshava Prasad T. S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., Telikicherla D., Raju R., Shafreen B., Venugopal A., Balakrishnan L., Marimuthu A., Banerjee S., Somanathan D. S., Sebastian A., Rani S., Ray S., Harrys Kishore C. J., Kanth S., Ahmed M., Kashyap M. K., Mohmood R., Ramachandra Y. I., Krishna V., Rahiman B. A., Mohan S., Ranganathan P., Ramabadran S., Chaerkady R., Pandey A., Human protein reference database-2009 update. Nucleic Acids Research 2009 37 1 D767 D772 2-s2.0-58149193222 10.1093/nar/gkn892
35. Bader G. D., Betel D., Hogue C. W. V., BIND: the biomolecular interaction network database. Nucleic Acids Research 2003 31 1 248 250 2-s2.0-0037245913 10.1093/nar/gkg056 (Pubitemid 36150376)
36. Kerrien S., Aranda B., Breuza L., Bridge A., Broackes-Carter F., Chen C., Duesbury M., Dumousseau M., Hinz U., Jandrasits C., Jimenez R. C., Khadake J., Mahadevan U., Masson P., Pedruzzi I., Pfeiffenberger E., Porras P., Raghunath A., Roechert B., Orchard S., Hermjakob H., The IntAct molecular interaction database in 2012. Nucleic Acids Research 2012 40 D1 D841 D846 10.1093/nar/gkr1088
37. Ceol A., Chatr Aryamontri A., Licata L., Peluso D., Briganti L., Perfetto L., Castagnoli L., Cesareni G., MINT, the molecular interaction database: 2009 update. Nucleic Acids Research 2009 38 1 D532 D539 2-s2.0-75549083295 10.1093/nar/gkp983 gkp983
38. Brown K. R., Jurisica I., Online predicted human interaction database. Bioinformatics 2005 21 9 2076 2082 2-s2.0-18744376914 10.1093/bioinformatics/ bti273 (Pubitemid 40668047)
39. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
40. Morris G. M., Goodsell D. S., Halliday R. S., Huey R., Hart W. E., Belew R. K., Olson A. J., Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 1998 19 14 1639 1662 2-s2.0-11644261806 (Pubitemid 128590223)
41. Yeh J. C., Cindrova-Davies T., Belleri M., Morbidelli L., Miller N., Cho C. W. C., Chan K., Wang Y. T., Luo G. A., Ziche M., Presta M., Charnock-Jones D. S., Fan T. P., The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis 2011 14 2 187 197 2-s2.0-79959975658 10.1007/s10456-011-9202- 8
42. Zamir E., Bastiaens P. I. H., Reverse engineering intracellular biochemical networks. Nature Chemical Biology 2008 4 11 643 647 2-s2.0-54249099099 10.1038/nchembio1108-643
43. Corson T. W., Crews C. M., Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 2007 130 5 769 774 2-s2.0-34548279788 10.1016/j.cell.2007.08.021 (Pubitemid 47332575)
44. Rix U., Superti-Furga G., Target profiling of small molecules by chemical proteomics. Nature Chemical Biology 2009 5 9 616 624 2-s2.0-69249136243 10.1038/nchembio.216
45. Canny S. A., Cruz Y., Southern M. R., Griffin P. R., PubChem promiscuity: a web resource for gathering compound promiscuity data from PubChem. Bioinformatics 2012 28 1 140 141 Article numberbtr622 10.1093/bioinformatics/ btr622
46. Lee K. W., Bode A. M., Dong Z., Molecular targets of phytochemicals for cancer prevention. Nature Reviews Cancer 2011 11 3 211 218 2-s2.0-79952012742 10.1038/nrc3017
47. Tang F. Y., Meydani M., Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutrition and Cancer 2001 41 1-2 119 125 2-s2.0-0035527489 (Pubitemid 34666231)
48. Chung A. S., Ferrara N., Targeting the tumor microenvironment with Src kinase inhibition. Clinical Cancer Research 2010 16 3 775 777 2-s2.0-76049127601 10.1158/1078-0432.CCR-09-3081
49. Roboz G. J., Dias S., Lam G., Lane W. J., Soignet S. L., Warrell R. P., Rafii S., Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 2000 96 4 1525 1530 2-s2.0-0034663032 (Pubitemid 30658486)
50. Minnear F. L., DeMichele M. A. A., Moon D. G., Rieder C. L., Fenton J. W., Isoproterenol reduces thrombin-induced pulmonary endothelial permeability in vitro. American Journal of Physiology 1989 257 5, part 2 H1613 H1623 2-s2.0-0024380872
51. Ou D. L., Shen Y. C., Liang J. D., Liou J. Y., Yu S. L., Fan H. H., Wang D. S., Lu Y. S., Hsu C., Cheng A. L., Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma. Clinical Cancer Research 2009 15 18 5820 5828 2-s2.0-70349452270 10.1158/1078-0432.CCR-08-3294
52. Pearce H. R., Kalia N., Bardhan K. D., Brown N. J., Effects of aspirin and indomethacin on endothelial cell proliferation in vitro. Journal of Gastroenterology and Hepatology 2003 18 10 1180 1187 2-s2.0-0242656097 10.1046/j.1440-1746.2003.03152.x (Pubitemid 37410049)
53. Nussinov R., Tsai C. J., Csermely P., Allo-network drugs: harnessing allostery in cellular networks. Trends in Pharmacological Sciences 2011 32 686 693